Delivery Order SPE2DX22D0010-SPE2D825FFW50

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $6.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,533,880 units of dextroamphetamine extended-release 10 mg capsules in 100-count bottles. The contract has a ceiling value of $4,123.42 and an ultimate completion date of March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 20 mg Dextroamphetamine-Amphetamine capsules, a pharmaceutical product, with a ceiling value of $2,358.04. The contract is a firm fixed-price, non-set-aside award with a performance period through May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.60, is for the delivery of 4,568,135,213 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,970,595 units of Dextroamphetamine Extended Release 15 mg capsules. The $1,135.04 firm fixed price award has a completion date of September 30, 2024 and was made on September 27, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20 mg dextroamphetamine-amphetamine capsules. The $3,884.60 contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10 mg Dextroamphetamine-Amphetamine capsules. The contract is a firm fixed-price delivery order with a ceiling value of $3,763.85 and a period of performance through April 2025. There is no set-aside designation, indicating the order was competed openly. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,316.52, is for the delivery of 10 mg capsules of the prescription medication dextroamphetamine-amphetamine. The contract is a firm-fixed price, non-set-aside delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is a for-profit organization that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,549 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with a ceiling value of $2,525.52 and a performance period extending through April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20mg Dextroamphetamine-Amphetamine capsules in 100-count bottles, with a ceiling value of $1,237.88 and a completion date of May 27, 2025. This contract is not set-aside and is awarded as a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,019,039 units of the prescription medication dextroamphetamine-amphetamine 15 mg capsules, with a ceiling value of $1,528.00. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is a firm fixed-price, non-set-aside contract....
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FFW50
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10mg dextroamphetamine sustained-release capsules. The contract has a firm fixed-price of $6,205.52 and a completion date of May 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support for military healthcare programs through December 2026. The contract is not set aside and is open to full and open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying the requested pharmaceutical product to support the medical needs of the U.S. government, particularly the Defense Health Agency and U.S. Coast Guard.

Generated 8/22/25, 10:00 AM